Detalhe da pesquisa
1.
COMPARE: Pharmacokinetic profiles of subcutaneous peginterferon beta-1a and subcutaneous interferon beta-1a over 2 weeks in healthy subjects.
Br J Clin Pharmacol
; 82(2): 380-8, 2016 08.
Artigo
Inglês
| MEDLINE | ID: mdl-27060836
2.
The impact of early remission on disease trajectory and patient outcomes in major depression disorder (MDD): A targeted literature review and microsimulation modeling approach based on the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study.
J Affect Disord
; 325: 264-272, 2023 03 15.
Artigo
Inglês
| MEDLINE | ID: mdl-36608852
3.
Impact of Treating Depression on Associated Comorbidities: A Systematic Literature Review.
Prim Care Companion CNS Disord
; 25(1)2023 Jan 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36638539
4.
Characterization of hypoactive sexual desire disorder (HSDD) in men.
J Sex Med
; 9(3): 812-20, 2012 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-22239825
5.
Impact of Major Depressive Disorder on Comorbidities: A Systematic Literature Review.
J Clin Psychiatry
; 83(6)2022 10 19.
Artigo
Inglês
| MEDLINE | ID: mdl-36264099
6.
Patient-reported health-related quality of life from a randomized, placebo-controlled phase 2 trial of zuranolone in adults with major depressive disorder.
J Affect Disord
; 308: 19-26, 2022 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35378149
7.
Number Needed to Treat and Number Needed to Harm analysis of the zuranolone phase 2 clinical trial results in major depressive disorder.
J Affect Disord
; 285: 112-119, 2021 04 15.
Artigo
Inglês
| MEDLINE | ID: mdl-33640861
8.
Effect of Zuranolone vs Placebo in Postpartum Depression: A Randomized Clinical Trial.
JAMA Psychiatry
; 78(9): 951-959, 2021 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34190962
9.
Patients transitioning from non-pegylated to pegylated interferon beta-1a have a low risk of new flu-like symptoms: ALLOW phase 3b trial results.
Mult Scler J Exp Transl Clin
; 5(1): 2055217318822148, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-30729026
10.
Synthesis and SAR studies of indole-based MK2 inhibitors.
Bioorg Med Chem Lett
; 18(6): 1994-9, 2008 Mar 15.
Artigo
Inglês
| MEDLINE | ID: mdl-18291646
11.
Characterizing Treatment Utilization Patterns for Trigeminal Neuralgia in the United States.
Clin J Pain
; 34(8): 691-699, 2018 08.
Artigo
Inglês
| MEDLINE | ID: mdl-29443722
12.
Pim kinase substrate identification and specificity.
J Biochem
; 141(3): 353-62, 2007 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-17234686
13.
Subcutaneous peginterferon ß-1a injection-site reaction experience and mitigation: Delphi analysis of the ALLOW study.
Neurodegener Dis Manag
; 7(1): 39-47, 2017 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-28071330
14.
Experimental autoimmune encephalomyelitis induction in peptidylarginine deiminase 2 knockout mice.
J Comp Neurol
; 498(2): 217-26, 2006 Sep 10.
Artigo
Inglês
| MEDLINE | ID: mdl-16856138
15.
Molecular basis of MAPK-activated protein kinase 2:p38 assembly.
Proc Natl Acad Sci U S A
; 104(15): 6353-8, 2007 Apr 10.
Artigo
Inglês
| MEDLINE | ID: mdl-17395714
16.
The discovery of carboline analogs as potent MAPKAP-K2 inhibitors.
Bioorg Med Chem Lett
; 17(16): 4664-9, 2007 Aug 15.
Artigo
Inglês
| MEDLINE | ID: mdl-17576063
17.
Discovery and characterization of a substrate selective p38alpha inhibitor.
Biochemistry
; 43(37): 11658-71, 2004 Sep 21.
Artigo
Inglês
| MEDLINE | ID: mdl-15362850
18.
Catalysis and function of the p38 alpha.MK2a signaling complex.
Biochemistry
; 43(31): 9950-60, 2004 Aug 10.
Artigo
Inglês
| MEDLINE | ID: mdl-15287722